QuantHealth Expands Executive Team with World-Class Medical and Innovation Leaders

QuantHealth Expands Executive Team with World-Class Medical and Innovation Leaders

Industry veterans from leading pharma and AI organizations will help build the predictive infrastructure that will power the future of clinical development

QuantHealth, the leader in AI-powered clinical trial simulation, today announced the appointment of four executives from the world’s top pharmaceutical and AI organizations to its executive team. The additions strengthen QuantHealth's leadership capabilities as predictive simulation emerges as a critical capability for pharmaceutical companies seeking to improve trial design, reduce development risks, and accelerate the delivery of new therapies to patients.

Joining the company are Francisco Beca, MD, PhD, as Chief Medical Officer; Sukant Mittal, MS, PhD, as Senior Vice President of Corporate Development and Strategy; Flavio Dormont, MBA, PhD, as Vice President of Scientific Strategy; and Agya Garg as Vice President of Product.

The appointments strengthen four of QuantHealth’s key strategic pillars for growth: clinical leadership, scientific innovation, corporate development, and product innovation. Collectively, the new executives bring experience from leading organizations including Merck, Sanofi, Seagen, Novartis, Hopper, Aura, and Loris.AI.